A 52-year-old woman from rural Maharashtra presents with progressive fatigue and dyspnea on exertion for 6 months. She reports a diet poor in vegetables and meat. On examination, she has glossitis and a sensory ataxia affecting her lower limbs. Her hemoglobin is 8.2 g/dL with a mean corpuscular volume (MCV) of 104 fL. Peripheral blood smear shows hypersegmented neutrophils. Serum vitamin B₁₂ level is 180 pg/mL (normal: 200–900). Serum folate is 3.2 ng/mL (normal: >5.4). What is the most appropriate next step in the workup?

Explanation

## Diagnostic Approach to Megaloblastic Anemia **Key Point:** When B₁₂ deficiency is confirmed biochemically (low serum B₁₂), the next step is to measure functional markers—serum methylmalonic acid (MMA) and homocysteine—to establish true B₁₂ deficiency and assess severity before determining the etiology. ### Why Methylmalonic Acid and Homocysteine? These are **functional metabolites** that accumulate in B₁₂ deficiency: - **Methylmalonic acid:** Elevated in B₁₂ deficiency (B₁₂ is a cofactor for methylmalonyl-CoA mutase) - **Homocysteine:** Elevated in both B₁₂ and folate deficiency - Both are more sensitive and specific than serum B₁₂ level alone, which can be falsely low in folate deficiency or pernicious anemia with high folate levels **High-Yield:** Elevated MMA + elevated homocysteine = true B₁₂ deficiency. Elevated homocysteine alone = folate deficiency. ### Workup Algorithm ```mermaid flowchart TD A[Macrocytic Anemia + Hypersegmented Neutrophils]:::outcome --> B[Measure B₁₂ and Folate]:::action B --> C{Both Low or B₁₂ Low?}:::decision C -->|B₁₂ Low| D[Measure MMA and Homocysteine]:::action C -->|Folate Low| E[Start Folate]:::action D --> F{MMA Elevated?}:::decision F -->|Yes| G[True B₁₂ Deficiency Confirmed]:::outcome F -->|No| H[Pseudodeficiency or Lab Error]:::outcome G --> I[Determine Etiology: Parietal Cell Antibody, Intrinsic Factor Antibody, or Dietary]:::action ``` ### Clinical Context in This Case - **Glossitis** and **sensory ataxia** = neurological manifestations of B₁₂ deficiency - **Poor diet** (no meat/vegetables) = dietary B₁₂ deficiency likely - **MCV 104 fL** = macrocytic - **Hypersegmented neutrophils** = megaloblastic process confirmed - **Low B₁₂ (180) + low folate (3.2)** = both deficient, but B₁₂ is the primary driver of neurological symptoms **Clinical Pearl:** Do NOT skip to Schilling test or bone marrow biopsy. Functional markers (MMA, homocysteine) are non-invasive, cost-effective, and guide the next diagnostic step (antibody testing vs. dietary counseling). ### Why Not the Other Options? - **Schilling test:** Historically used to differentiate pernicious anemia from dietary deficiency, but is now rarely available and not performed until B₁₂ deficiency is functionally confirmed. - **Bone marrow biopsy:** Invasive and unnecessary—peripheral blood smear already shows megaloblastic changes. Reserved for cases where diagnosis remains unclear after biochemical workup. - **Start treatment without testing:** While B₁₂ replacement is indicated, confirming functional deficiency first allows targeted etiology workup and prevents masking of folate deficiency. **Mnemonic:** **MAHA** = Methylmalonic Acid, Homocysteine Assessment (after confirming low B₁₂ level).